Paige Prologo-Richardson
Toledo, OHNPI 1144969304
Payments from drug & device makers
Across 59 payments — averaging $28.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$264
- Neurelis, Inc.$232
- AbbVie$166
- SK Life Science, Inc.$129
- Teva Pharmaceuticals USA, Inc.$128
- CSL Behring$125
- plus $654 from 17 others
What the payments were for
- Food & beverage$1,698100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 3 | $264 |
| Neurelis, Inc. | 7 | $232 |
| AbbVie | 3 | $166 |
| SK Life Science, Inc. | 7 | $129 |
| Teva Pharmaceuticals USA, Inc. | 4 | $128 |
| CSL Behring | 1 | $125 |
| Biogen | 5 | $111 |
| Jazz Pharmaceuticals Inc. | 4 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $77 |
| Argenx US, Inc. | 3 | $58 |
| Merz Pharmaceuticals, LLC | 3 | $55 |
| Catalyst Pharmaceuticals, Inc. | 3 | $52 |
| Lilly USA, LLC | 2 | $31 |
| Genentech USA, Inc. | 1 | $28 |
| TG Therapeutics, Inc. | 1 | $26 |
| Lundbeck LLC | 1 | $23 |
| Amneal Pharmaceuticals LLC | 1 | $20 |
| Amgen | 1 | $17 |
| Johnson & Johnson | 1 | $15 |
| EMD Serono, Inc. | 1 | $15 |
| Neurocrine Biosciences, Inc. | 1 | $14 |
| Acadia Pharmaceuticals Inc | 1 | $14 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 26 | $738 |
| Gabapentin | 33 | $443 |
| Donepezil Hcl | 13 | $103 |
| Atorvastatin Calcium | 13 | $97 |
| Lamotrigine | 25 | $93 |
| Topiramate | 18 | $64 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.